• GTP Solution Empowers p21 mRNA-LNP Bladder Cancer Therapy

  2026-07-14

  High-purity GTP Solution (100 mM) from APExBIO is pivotal for in vitro transcription workflows driving next-generation mRNA therapeutics. Explore how its unmatched purity, stability, and protocol-ready format accelerate p21 mRNA–LNP production for localized bladder cancer therapy, with practical troubleshooting and advanced application insights.

• Ellagic Acid: Precision CK2 Inhibition for Cancer Biology Re

  2026-07-14

  Ellagic acid, a selective ATP-competitive CK2 inhibitor, empowers researchers to dissect kinase-driven cancer pathways with unparalleled specificity. Leveraging recent machine learning breakthroughs and optimized protocols, this guide reveals how to maximize the translational impact of Ellagic acid in apoptosis and oxidative stress assays.

• Neticonazole Hydrochloride: Dual-Action Imidazole Antifungal

  2026-07-13

  Neticonazole Hydrochloride is a dual-action imidazole antifungal with established efficacy for cutaneous candidiasis and emerging utility in colorectal cancer models. Its mechanism includes inhibition of fungal cell membrane synthesis and modulation of exosome secretion linked to tumor progression. This dossier compiles peer-reviewed and product-based evidence for clinical and translational use.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-07-13

  This study reveals that naturally occurring angiotensin peptides, including Angiotensin (1-7), can significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. The findings highlight a novel intersection between vascular peptide biology and COVID-19 pathogenesis, suggesting new research directions for understanding host susceptibility and therapeutic targeting.

• Fluconazole as a Fungal Cytochrome P450 Enzyme 14α-Demethyla

  2026-07-12

  Leverage the precision and reproducibility of Fluconazole in dissecting fungal pathogenesis, antifungal resistance, and host-pathogen interactions. This guide delivers actionable protocols and troubleshooting tips for optimizing in vitro and in vivo Candida research workflows with APExBIO’s trusted standards.

• Rotenone as a Precision Tool: Mitochondrial Complex I Inhibi

  2026-07-10

  Explore how Rotenone, a potent mitochondrial Complex I inhibitor, enables advanced research into mitochondrial quality control and neurodegenerative diseases. This article uniquely integrates recent insights into peroxisome-mitochondria dynamics, providing deeper context for autophagy and apoptosis pathway investigations.

• Aprotinin in Research: Optimizing Serine Protease Inhibition

  2026-07-09

  Aprotinin (Bovine Pancreatic Trypsin Inhibitor, BPTI) empowers researchers to achieve precise, reversible serine protease inhibition for applications ranging from cardiovascular surgery models to advanced genomic assays. Learn how to maximize assay reproducibility, manage perioperative blood loss in experimental models, and troubleshoot common workflow challenges using this versatile reagent.

• Platanoside Mitigates Ferroptosis in Acute Lung Injury via K

  2026-07-09

  The reference study demonstrates that platanoside, a flavonoid glycoside, protects against acute lung injury (ALI) by promoting autophagic degradation of Keap1 and activating the Nrf2/GPX4 pathway, thus inhibiting ferroptosis. These findings underscore the mechanistic importance of targeting redox homeostasis and ferroptosis in ALI, offering new avenues for therapeutic intervention and research.

• Bsa I (RNase-free): Technical Guidance for DNA Manipulation

  2026-07-08

  Bsa I (RNase-free) provides precise DNA cleavage suitable for workflows requiring strict RNA integrity, such as gene cloning and DNA recombinant technology. It is designed exclusively for research use and should not be applied in diagnostic or medical contexts.

• D-Luciferin Potassium Salt: Driving Translational Imaging Fo

  2026-07-08

  This thought-leadership article examines the mechanistic, strategic, and translational dimensions of D-Luciferin potassium salt as a gold-standard substrate for in vivo bioluminescence imaging. Offering insights from recent oncology models—including glioma nanoparticle delivery—and integrating best practices from leading literature and APExBIO’s product intelligence, it guides researchers in maximizing reproducibility, sensitivity, and clinical relevance for next-generation tumor and cell tracking workflows.

• ARCA in mRNA Therapeutics: Mechanisms, Strategy, and Impact

  2026-07-07

  This thought-leadership article explores the pivotal role of Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G in maximizing synthetic mRNA translation. By integrating mechanistic detail, evidence from translational studies, and strategic protocol guidance, we map ARCA's transformative potential for next-generation mRNA therapeutics. The discussion bridges biological insight and practical utility, providing actionable recommendations for researchers seeking clinical readiness and workflow optimization.

• Staurosporine Induces PANoptosis: Redefining Cell Death Path

  2026-07-07

  This study reveals that staurosporine, a classical apoptotic stimulus, can induce lytic inflammatory cell death (PANoptosis) via the caspase-8/RIPK3 axis. These findings prompt a reassessment of how apoptosis inducers are understood in innate immunity and highlight the necessity for precise tools in dissecting overlapping cell death mechanisms.

• Lipid Nanoparticle Delivery of ABE8e for COL7A1 Correction i

  2026-07-06

  This study demonstrates efficient delivery of the adenine base editor ABE8e via lipid nanoparticles to correct pathogenic COL7A1 mutations in fibroblasts from dystrophic epidermolysis bullosa (DEB) patients. The findings establish a proof-of-concept for RNA-based gene editing of inherited skin disorders, with implications for translational dermatology and mRNA delivery optimization.

• Applied Pyridostatin TFA Workflows in Telomere & ALS Researc

  2026-07-06

  Pyridostatin TFA enables targeted G-quadruplex stabilization, unlocking robust telomere biology and neurodegeneration assays. Its selectivity and reproducibility make it indispensable for cancer and protein aggregation studies, empowering researchers to interrogate disease mechanisms and accelerate anticancer drug development.

• Anti Reverse Cap Analog: Enhancing mRNA Transcription Yields

  2026-07-05

  Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, delivers superior translation efficiency and mRNA stability in demanding research workflows. Explore how ARCA integrates into advanced mRNA synthesis, enabling robust protein expression for therapeutic and experimental innovation.

16007 records 1/1068 page Next 12345 下5页 Last page